TN
Tango Ther
TNGX·NASDAQCambridge MAFounded 2017200 employees
Small CapbiotechPublicOncology
Platform: Synth Leth
Market Cap
$1.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (TNGX)
Loading TNGX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Polazanubrutinib | TNG-210 | Phase 1 | 2 | IL-17A | MCLFabry | ||
| TNG-8610 | TNG-8610 | NDA/BLA | 2 | GIP-R | ALSRB |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)